Revolution Medicines, Inc. (RVMD) — Stock Score Summary

Revolution Medicines, Inc. (RVMD) has a MoatMap StockRank of 48/100 based on Quality (26/100), Value (34/100), and Momentum (73/100) factor scores. The current signal is HOLD. Revolution Medicines is a development-stage biotech company with no current product revenues, failing our fundamental quality and cash flow screens.

Revolution Medicines, Inc. is a clinical-stage biotechnology company focused on developing targeted therapies for RAS-addicted cancers using its proprietary RAS(ON) inhibitor platform. Its innovative approach to directly target oncogenic RAS proteins, historically considered undruggable, positions it at the forefront of cancer drug development. The company is a specialized oncology biotech pioneering novel small molecule inhibitors for a challenging class of cancer targets.

Key Financial Metrics

Price$149.55
Market Cap$32.9B
P/E (Forward)-27.61
Price/Book20.78
Return on Equity-76.7%
Return on Invested Capital-53.6%
Debt/Equity29.15
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-606M

Revolution Medicines, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Revolution Medicines, Inc.’s (RVMD) StockRank?
MoatMap’s StockRank for Revolution Medicines, Inc. (RVMD) is 48/100, with a Hold signal. It is a composite of Quality (26), Value (34), and Momentum (73) factor ranks across MoatMap’s 19,000+ stock universe.
Does Revolution Medicines, Inc. have an economic moat?
Revolution Medicines, Inc. (RVMD) has a Quality factor score of 26/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Revolution Medicines, Inc. a buy, hold, or sell?
MoatMap’s current signal for Revolution Medicines, Inc. (RVMD) is Hold, based on a StockRank of 48/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Revolution Medicines, Inc. in?
Revolution Medicines, Inc. (RVMD) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksRVMD deep dive reportAI ChampionsHow we score stocksSense-check another stock